trending Market Intelligence /marketintelligence/en/news-insights/trending/9t6uqgkswk3btepvcv3yeq2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Oncobiologics to issue notes, warrants

State Of Indonesian Online Video: Subscription

Virtual Multichannel Revenues Projected To Soar In Next Five Years

Street Talk Episode 45 - Fed Moving From Rate Hikes To Lower For Longer

Consumer Engagement Remains Challenging For OTT Players In Asia


Oncobiologics to issue notes, warrants

Oncobiologics Inc. agreed to issue and sell to existing investors up to $10 million of senior secured promissory notes and five-year warrants to acquire 2.3 million common shares of the company.

The notes bear interest rates of 5.0% per year with a one-year maturity, while the warrants have an exercise price of $3 per share.

At the initial closing, the company issued about $8.4 million of notes and 1,920,500 warrants. The company may issue up to about $1.7 million of additional notes and 379,500 warrants in additional closings without approval of the note holders.

Oncobiologics used a portion of the proceeds to pay off existing senior secured bank loans and will use the rest for working capital purposes as it pursues strategic opportunities.